Journal article
Policy Statement-Prevention of Varicella: Update of Recommendations for Use of Quadrivalent and Monovalent Varicella Vaccines in Children
Pediatrics (Evanston), v 128(3), pp 630-632
01 Sep 2011
PMID: 21873692
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Two varicella-containing vaccines are licensed for use in the United States: monovalent varicella vaccine (Varivax [Merck & Co, Inc, West Point, PA]) and quadrivalent measles-mumps-rubella-varicella vaccine (MMRV) (ProQuad [Merck & Co, Inc]). It is estimated from postlicensure data that after vaccination at 12 through 23 months of age, 7 to 9 febrile seizures occur per 10 000 children who receive the MMRV, and 3 to 4 febrile seizures occur per 10 000 children who receive the measles-mumps-rubella (MMR) and varicella vaccines administered concurrently but at separate sites. Thus, 1 additional febrile seizure is expected to occur per approximately 2300 to 2600 children 12 to 23 months old vaccinated with the MMRV, when compared with separate MMR and varicella vaccine administration. The period of risk for febrile seizures is from 5 through 12 days after receipt of the vaccine(s). No increased risk of febrile seizures is seen among patients 4 to 6 years of age receiving MMRV. Febrile seizures do not predispose to epilepsy or neurodevelopmental delays later in life and are not associated with long-term health impairment. The American Academy of Pediatrics recommends that either MMR and varicella vaccines separately or the MMRV be used for the first dose of measles, mumps, rubella, and varicella vaccines administered at 12 through 47 months of age. For the first dose of measles, mumps, rubella, and varicella vaccines administered at ages 48 months and older, and for dose 2 at any age (15 months to 12 years), use of MMRV generally is preferred over separate injections of MMR and varicella vaccines. Pediatrics 2011; 128: 630-632
Metrics
Details
- Title
- Policy Statement-Prevention of Varicella: Update of Recommendations for Use of Quadrivalent and Monovalent Varicella Vaccines in Children
- Creators
- Michael T. BradyHenry H. BernsteinCarrie L. ByingtonKathryn M. EdwardsMargaret C. FisherMary P. GlodeMary Anne JacksonHarry L. KeyserlingDavid W. KimberlinYvonne A. MaldonadoWalter A. OrensteinGordon E. SchutzeRodney E. WilloughbyCommittee on Infectious Diseases
- Publication Details
- Pediatrics (Evanston), v 128(3), pp 630-632
- Publisher
- Amer Acad Pediatrics
- Number of pages
- 3
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pediatrics
- Web of Science ID
- WOS:000295406100063
- Scopus ID
- 2-s2.0-80052343820
- Other Identifier
- 991021930430304721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Pediatrics